Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02003612 · ClinicalTrials.gov registry record
Historical Data Analysis of Hematological Remission and Survival in Adults With R/R Acute Lymphoblastic Leukemia
A clinical trial, sponsored by Amgen.
- Completed
- Registry status
- 2,373
- Enrollment target
NCT02003612 is a clinical trial that has completed, run by Amgen. The registered enrollment target is 2,373 participants.
The verdict
NCT02003612 has completed, sponsored by Amgen.
- COMPLETED
- Registry status
- 2,373 participants
- Enrollment target
Study Summary
A retrospective analysis of historical data looking at hematological remission and survival in adult relapsed / refractory B-precursor acute lymphoblastic leukemia patients.
Interventions
- OTHER Not applicable - observational study
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 2,373 participants |
| Start Date | 2013-10-01 |
| Est. Completion | 2014-04-28 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02003612
The ClinicalTrials.gov registry entry for NCT02003612 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 2,373 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Amgen, which has 558 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Not applicable - observational study is the first listed.
NCT02003612 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02003612 about?
NCT02003612 is a clinical study titled "Historical Data Analysis of Hematological Remission and Survival in Adults With R/R Acute Lymphoblastic Leukemia". A retrospective analysis of historical data looking at hematological remission and survival in adult relapsed / refractory B-precursor acute lymphoblastic leukemia patients.
What is the current status of trial NCT02003612?
This trial is currently completed. The enrollment target is 2,373 participants. The study started on 2013-10-01. Estimated completion is 2014-04-28.
What interventions are being tested in trial NCT02003612?
The interventions under investigation include: Not applicable - observational study (OTHER).
Who is sponsoring clinical trial NCT02003612?
This trial is sponsored by Amgen, which has 558 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.